Published October 26, 2024
| Version v1
Other
Open
Effectiveness of COVID-19 vaccines against severe acute respiratory infections hospitalization associated with laboratory-confirmed SARS-CoV-2 over a two period in Ghana
Creators
- Amoako, Nicholas (Researcher)
- Cohuet, Sandra (Researcher)
- Rockson, Michael (Researcher)
- Gurry, Celine
- Oduro, Abraham
- Agyapong, Prince
- Musah, Osei
- Asantewaa, Ivy Asante
- Mensah, Anthony Affum
- Djanie, Reuben Ayivor
- Duedu, Kwabena
- Kenu, Ernest
- Adjei, George Obeng
- Dabo, Ellis Owusu
- Amuasi, John
- Asiedu-Bekoe, Franklin
- Laryea, Dennis
- Kasolo, Francis
- Ohene, Sally-Ann
- Rose, Angie
- Nardone, Anthony
- Archibald, Worwui Kwame
- Humphreys, James
- Ampofo, William
- Owusu-Agyei, Seth
- Mwenda, Jason
- Asante, Kwaku Poku
Description
The use of vaccines to respond to the COVID-19 pandemic required vaccine effectiveness monitoring in the context of newviral variants and changing epidemiology. This study measured COVID-19 vaccine effectiveness (VE) against laboratory-confi rmed SARS-CoV-2 in hospitalized patients diagnosed with severe acute respiratory infections (SARI).
Files
UHASRC202415085-1.pdf
Files
(40.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:ead72be2cdec615431f13106c1e70838
|
40.6 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-10-26University of Health and Allied Scienes